Efficacy of Dry Needling in the Spasticity Post-stroke

NCT ID: NCT04435561

Last Updated: 2020-12-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-15

Study Completion Date

2021-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Stroke is a serious clinical condition and one of the leading causes of long-term disability in the world. One of the most serious complications of this condition is spasticity. Recently, dry needling has commented to be used as a treatment in muscle spasticity of chronic patients after a stroke, producing improvements in clinical conditions.

This study evaluates the effectiveness of dry needling technique in the spasticity of the hemiparetic limbs in chronic post-stroke patients. The Modified Ashworth Scale is used to measure the spasticity´s improvement after the procedure.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Spasticity, Muscle

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

dry needling spasticity hypertonia stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Standard physiotherapy rehabilitation and dry needling

In addition to the usual therapy, the experimental group will receive the application of dry needling technique in the hemiparetic limbs.

Dry needling intervention will take place over a period of one and a half months (6 weeks), with a total of 6 sessions. Each session will be performed once a week, where a single puncture will be made in each muscle to be treated, using Hong´s technique and lasting 60 seconds per muscle (or until the muscle is release).

The muscles that will receive dry needling are the following ones:

* Upper limb: infraspinatus, teres minor, pectoralis major, deltoid.
* Lower limb: gastrocnemius, soleus and anterior tibial muscles.

Group Type EXPERIMENTAL

Standard physiotherapy rehabilitation and dry needling

Intervention Type OTHER

The dry needling group receives 6 sessions of dry needling in the spastic muscles of the upper and lower hemiparetic limbs.

Standard physiotherapy rehabilitation

The control group will receive the usual therapy and treatment.

Group Type OTHER

Standard physiotherapy rehabilitation

Intervention Type OTHER

This group receives their traditional intervention, without dry needling.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Standard physiotherapy rehabilitation and dry needling

The dry needling group receives 6 sessions of dry needling in the spastic muscles of the upper and lower hemiparetic limbs.

Intervention Type OTHER

Standard physiotherapy rehabilitation

This group receives their traditional intervention, without dry needling.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* First hemiplegic ischemic stroke.
* Chronic stroke (stroke at least 6 months before the trial).
* Present a level of spasticity equal or greater than 1 according to the Modified Asworth Scale.
* Preserve cognitive capacity.
* Being able to understand and follow simple instructions.
* Not afraid of needles.

Exclusion Criteria

* Recurrent stroke.
* Subjects with cognitive disorders.
* Presenting any medical contraindication for the dry needling procedure or problems with coagulation or epilepsy.
* Alteration of sensitivity.
* Receives nerve block or botulinum toxin treatments in a period equal or less than 6 months, since ir can modify the results.
* Hemorrhagic stroke.
* Subjects who do not consent to participate in the study.
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Malaga

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rocío Martín Valero

PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rocío Martin Valero, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Malaga

Juan Antonio Armenta Peinado, PhD

Role: STUDY_DIRECTOR

University of Malaga

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Rocío Martín Valero, PhD

Role: CONTACT

Phone: 34 951 95 28 58

Email: [email protected]

Angela Ramos Villodres

Role: CONTACT

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UMADryNeed

Identifier Type: -

Identifier Source: org_study_id